Natural Shrimp Inc. announced it has completed at the end of February 2024 a successful 6-month trial in Japan with the Company's patented Electrocoagulation (EC) and Hydrogas? technologies (the Equipment). One week after arriving in Japan, the Natural Shrimp and Hydrenesis' team, with the assistance of the Japanese team, installed and began operating the Equipment at the Japanese shrimp research facility.

The trial compared a tank treated by the EC and Hydrogas? with a tank treated by a traditional biofilter. Throughout the 6-month trial, the EC effectively removed the ammonia from the water.

In addition, the shrimp growth rate increased during the presence of Hydrogas when compared to the shrimp growth rate in the tank treated only by the biofilter. Natural Shrimp supported the trial by making three trips to Japan during the Trial Period and continued to actively participate in the Trial by remote access to the Equipment between trips. However, after initial instruction by the NSI team, the Japanese team was able to independently operate the EC and Hydrogas equipment on their own.

The Japanese team performed extensive testing of the Equipment that included, among other things, collecting data under varying conditions by testing different flow rates, ammonia levels, and amperage levels. Based on the empirical results demonstrated by the Equipment during the Trial, Natural Shrimp looks to either joint venture, License or form a business combination in Japan.